United Therapeutics (UTHR) Misses Q2 EPS by 94c
Tweet
Share
E-mail
Get Alerts UTHR Hot Sheet
Price: $508.48 --0%
Financial Fact:
Net product sales: 408.2M
Today's EPS Names:
HSAI, SYRS, EGRX, More
Financial Fact:
Net product sales: 408.2M
Today's EPS Names:
HSAI, SYRS, EGRX, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q2 EPS of $6.41, $0.94 worse than the analyst estimate of $7.35. Revenue for the quarter came in at $798.6 million versus the consensus estimate of $804.98 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna shares tumble on weak full-year revenue guidance
- Sypris Solutions (SYPR) Reports Q2 Loss of $0.14
- Lakeland Industries qualifies Vietnam cleanroom for critical environment output
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
